Manchester Keith S
- SEC CIK
- 0001244828
In the past year, 1 open-market sale filing worth $7.09M and no purchases.
Current role at each company
- ROIV Roivant Sciences Ltd.Directoras of Sep 18, 2026
- ABUS Arbutus Biopharma CorpDirectoras of Aug 16, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.09M
- 1 filing
- Net
- −$7.09M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Manchester Keith S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ROIV Roivant Sciences Ltd.
Director8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 (view filing) | Nov 10 | 4 days | Manchester Keith SDirector | SSale | −3.92M | $4.75 | −$18.6M | −41.8%5.47M after | 4 lots |
| Oct 2, 2023 (view filing) | Sep 28 | 4 days | Manchester Keith SDirector | SSale | −6.90M | $11.55 | −$79.7M | −57.9%5.02M after | 4 lots |
| Sep 26, 2024 (view filing) | Sep 24-25 | 2 days | Manchester Keith SDirector | SSale | −503.0K | $11.67 | −$5.87M | −28.3%1.28M after | 2 lots |
| Nov 21, 2025 (view filing) | Nov 19 | 2 days | Manchester Keith SDirector | SSale | −1.30M | $20.23 | −$26.3M | −6.7%18.0M after | 4 lotsDuplicate filing |
| Dec 18, 2025 (view filing) | Dec 16-17 | 2 days | Manchester Keith SDirector | SSale | −1.69M | $23.05 | −$39.1M | −9.4%16.4M after | 5 lotsDuplicate filing |
| Feb 13, 2026 (view filing) | Feb 11-13 | 2 days | Manchester Keith SDirector | SSale | −1.23M | $26.64 | −$32.7M | −7.5%15.1M after | 5 lotsDuplicate filing |
| Jun 30, 2026 (view filing) | Jun 26-30 | 4 days | Manchester Keith SDirector | SSale | −1.44M | $34.32 | −$49.4M | −9.5%13.7M after | 5 lotsDuplicate filing |
| Jun 30, 2026 (view filing) | Jun 30 | Same day | Manchester Keith SDirector | SSale | −200.0K | $35.45 | −$7.09M | −10.3%1.75M after |
ABUS Arbutus Biopharma Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 (view filing) | Aug 14 | 2 days | Manchester Keith SDirector | SSale | −8.85K | $3.69 | −$32.6K | −16.1%46.1K after |